US$ 22.61
fda approved glp-1 agonists Pharmacovigilance Assessment of Compounded Receptor Agonists: Insights From the Adverse Event Reporting System DID YOU KNOW? GLP-1 medications
Description
Kenakin T, Christopoulos A
What monitoring

J Clin Invest 129: 37863791

Poddar MK, Banerjee S, Chakraborty A, Dutta D

Europe: The European Medicines Agency oversees the approval of incretin mimetics, with drugs like Exenatide and Semaglutide approved since 2008
